Skip to content
AgPlus logo
  • Home
  • Agilis Reader
    • Our Technology Platform
    • Reader Connectivity
  • About
    • Quality
  • Products & Services
    • Contract Development
    • Contract Manufacturing
    • Biomarkers
    • Antimicrobial Resistance
  • White Papers
  • People
  • Customer Care
  • Contact
  • News
Menu
  • Home
  • Agilis Reader
    • Our Technology Platform
    • Reader Connectivity
  • About
    • Quality
  • Products & Services
    • Contract Development
    • Contract Manufacturing
    • Biomarkers
    • Antimicrobial Resistance
  • White Papers
  • People
  • Customer Care
  • Contact
  • News

Category: Clinical Updates

Success of COVID-19 Antibody Assay Development

We are developing two assays to support the COVID-19 diagnostic effort. AgPlus has been working on an antigen assay and antibody assay.

Development and Manufacture of Our Diagnostic Reader with Key Partner STI

Key Partner STI supports Ground-breaking Antibiotic Resistance Project

In Vitro Diagnostic Regulations. The Impact of Implementation on SME’s

White Paper : The impact of implementing the new In Vitro Diagnostic Regulations on SMEs

The Simultaneous Detection of Two Analytes on the Agilis System Using Silver and Gold Nanoparticles

Agilis Reader

Ag Plus release new white paper – This piece of work has shown that dual detection system for two different analytes can be accomplished on the AgPlus system using differing AuNP and AgNP simultaneously.

Top five problems of developing a near patient diagnostic assay.

We discuss the problems of developing a near patient diagnostic assay…

AG Plus release White Paper – using a Point of Care Assay to detect Human Neutrophil Lipocalin

Every 4 minutes worldwide someone dies from infection caused by bacteria that are resistant to antibiotics. Using a Point of Care Assay to detect Human Neutrophil Lipocalin would improve patient outcome.

AG Plus release Challenges to Point-of-Care Testing White Paper

Consultation with Doctor - Near patient testing

Point-of-care tests (POCT) offer rapid diagnostic and/or predictive results in real-time thereby facilitating clinical decision making. We discuss how our technology overcomes implementation challenges.

Menu

  • Home
  • Agilis Reader
  • Products & Services
  • White Papers
  • About Us
  • News
  • Contact Us
  • Home
  • Agilis Reader
  • Products & Services
  • White Papers
  • About Us
  • News
  • Contact Us

Links

  • Contract Manufacturing
  • Develop Your Test With Us
  • Biomarkers
  • Our Technology Platform
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • Contract Manufacturing
  • Develop Your Test With Us
  • Biomarkers
  • Our Technology Platform
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy

Contact

The Exchange, Colworth Science Park, Sharnbrook

Bedfordshire, MK44 1LZ

t +44 (0)1234 867 100

e info@agplusdiagnostics.com

     

Copyright © 2022 AgPlus Diagnostics. All Rights Reserved. Site Map. Website by activ Strategic Marketing